LBRX
NASDAQ · Pharmaceuticals
Lb Pharmaceuticals Inc
$31.97
-0.01 (-0.03%)
Open$31.68
Previous Close$31.98
Day High$32.83
Day Low$30.66
52W High$33.47
52W Low$13.36
Volume—
Avg Volume153.9K
Market Cap917.02M
P/E Ratio—
EPS$-1.05
SectorPharmaceuticals
Analyst Ratings
Strong Buy
12 analysts
Price Target
-52.4% upside
Current
$31.97
$31.97
Target
$15.21
$15.21
$11.61
$15.21 avg
$18.52
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 167.53M | 154.99M | 171.21M |
| Net Income | 47.95M | 36.94M | 41.17M |
| Profit Margin | 28.6% | 23.8% | 24.1% |
| EBITDA | 61.52M | 61.45M | 59.09M |
| Free Cash Flow | 46.38M | 48.44M | 62.84M |
| Rev Growth | -8.2% | -9.0% | +5.4% |
| Debt/Equity | 1.06 | 1.00 | 0.91 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |